These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 6681033)
41. Time course of plasma corticosterone, 18-hydroxycorticosterone and aldosterone concentrations following CRF administration in the rat. A phase of corticosterone inhibition. Maser-Gluth C; Toygar A; Vecsei P Life Sci; 1984 Aug; 35(8):879-84. PubMed ID: 6090854 [TBL] [Abstract][Full Text] [Related]
42. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. Witzgall H; Lorenz R; von Werder K; Weber PC Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312 [TBL] [Abstract][Full Text] [Related]
43. Evidence for an ultradian secretion of adrenocorticotropin, beta-endorphin and alpha-melanocyte-stimulating hormone by the ovine anterior and intermediate pituitary. Engler D; Pham T; Fullerton MJ; Clarke IJ; Funder JW Neuroendocrinology; 1989 Apr; 49(4):349-60. PubMed ID: 2541359 [TBL] [Abstract][Full Text] [Related]
44. The unique patterns of plasma aldosterone and 18-hydroxycorticosterone concentrations in the 17 alpha-hydroxylase deficiency syndrome. Kater CE; Biglieri EG; Brust N; Chang B; Hirai J J Clin Endocrinol Metab; 1982 Aug; 55(2):295-302. PubMed ID: 7045152 [No Abstract] [Full Text] [Related]
45. The determination of 18-hydroxycorticosterone in saliva and plasma: comparison with aldosterone and glucocorticoids. Lee CY; Few JD; James VH J Steroid Biochem; 1988 May; 29(5):511-7. PubMed ID: 2837609 [TBL] [Abstract][Full Text] [Related]
46. Evidence for altered hypothalamus-pituitary-adrenal axis functioning in systemic hypertension: blunted cortisol response to awakening and lower negative feedback sensitivity. Wirtz PH; von Känel R; Emini L; Ruedisueli K; Groessbauer S; Maercker A; Ehlert U Psychoneuroendocrinology; 2007 Jun; 32(5):430-6. PubMed ID: 17433557 [TBL] [Abstract][Full Text] [Related]
47. Aldosterone suppression with dopamine infusion in low-renin hypertension. Holland OB; Thomas C; Brown H; Schindewolf D; Hillier Y; Gomez-Sanchez C J Clin Invest; 1983 Sep; 72(3):754-66. PubMed ID: 6309909 [TBL] [Abstract][Full Text] [Related]
48. Rhythm characteristics of plasma renin, aldosterone and cortisol in five subtypes of mesor-hypertension. Cugini P; Manconi R; Serdoz R; Mancini A; Meucci T; Scavo D J Endocrinol Invest; 1980; 3(2):143-7. PubMed ID: 6248590 [TBL] [Abstract][Full Text] [Related]
49. Circadian rhythm of plasma aldosterone and time dependent alterations of aldosterone regulators. Takeda R; Miyamori I; Ikeda M; Koshida H; Takeda Y; Yasuhara S; Morise T; Takimoto H J Steroid Biochem; 1984 Jan; 20(1):321-3. PubMed ID: 6323866 [TBL] [Abstract][Full Text] [Related]
50. 18-Hydroxycorticosterone as a marker for primary hyperaldosteronism. Lapworth R; Short F; James VH Ann Clin Biochem; 1989 May; 26 ( Pt 3)():227-32. PubMed ID: 2669615 [TBL] [Abstract][Full Text] [Related]
51. The possible role of beta-endorphin in pathogenesis of obesity and essential hypertension. Slowinska-Srzednicka J; Zgliczynski S; Soszynski P; Wierzbicki M; Jeske W Clin Exp Hypertens A; 1988; 10(1):135-49. PubMed ID: 2832103 [TBL] [Abstract][Full Text] [Related]
52. Bromocriptine alters hormone rhythms and lipid metabolism in swine. Cincotta AH; Meier AH; Southern LL Ann Nutr Metab; 1989; 33(6):305-14. PubMed ID: 2694921 [TBL] [Abstract][Full Text] [Related]
53. Activation of dopamine D2 receptors lowers circadian leptin concentrations in obese women. Kok P; Roelfsema F; Frölich M; van Pelt J; Meinders AE; Pijl H J Clin Endocrinol Metab; 2006 Aug; 91(8):3236-40. PubMed ID: 16705078 [TBL] [Abstract][Full Text] [Related]
54. Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism. Miyamori I; Takeda Y; Takasaki H; Itoh Y; Iki K; Takeda R J Endocrinol Invest; 1992 Jan; 15(1):19-24. PubMed ID: 1560187 [TBL] [Abstract][Full Text] [Related]
55. Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism. Fraser R; Beretta-Piccoli C; Brown JJ; Cumming AM; Lever AF; Mason PA; Morton JJ; Robertson JI Hypertension; 1981; 3(3 Pt 2):I87-92. PubMed ID: 7262982 [TBL] [Abstract][Full Text] [Related]
56. Plasma corticosteroids in hyperreninemic hypoaldosteronism: evidence for diffuse impairment of the zona glomerulosa. Stern N; Beck FW; Sowers JR; Tuck M; Hsueh WA; Zipser RD J Clin Endocrinol Metab; 1983 Jul; 57(1):217-20. PubMed ID: 6304133 [TBL] [Abstract][Full Text] [Related]